Results 211 to 220 of about 69,966 (266)

[Changes in serum HBV-DNA in various types of HBV infection and their clinical significance].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988
openaire   +2 more sources

[Detection of HBV DNA by the in situ hybridization method].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1986
openaire   +2 more sources

Blood Screening for HBV DNA

Journal of Clinical Virology, 2006
The safety of the blood supply has been greatly improved in the past two decades owing to continuous improvement in the technology and sensitivity of laboratory testing, better donor education and selection, and tighter quality control on blood bank operations.
openaire   +2 more sources

State of HBV DNA in HBsAg‐negative, anti‐HCV‐positive hepatocellular carcinoma: Existence of HBV DNA possibly as nonintegrated form with analysis by Alu‐HBV DNA PCR and conventional HBV PCR

Journal of Medical Virology, 2001
AbstractThe role of hepatitis B virus (HBV) in carcinogenesis of hepatitis B surface antigen (HBsAg)‐negative, anti‐hepatitis C virus (anti‐HCV)‐positive hepatocellular carcinoma (HCC) remains unknown. To investigate the state of HBV DNA in such HCC, HBV DNA was examined by polymerase chain reaction (PCR) between HBV DNA and human Alu sequence (HBV‐Alu
S, Kawai   +4 more
openaire   +2 more sources

Studies on the structure of HBV DNA.

Science in China. Series B, Chemistry, life sciences & earth sciences, 1989
The structure of HBV adr NC-1 DNA is analyzed and compared with another five strains of HBV DNAs. Some of the prokaryotic promoter-like sequences, palindrom sequences and ATAA are found. An enhancer core sequence and some other characteristics are also shown.
Qi, ZH, Yan, J, Zhu, QL
openaire   +3 more sources

A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA

Journal of Gastroenterology
Currently, standard treatments for chronic hepatitis B such as nucleos(t)ide analogs (NAs), effectively reduce hepatitis B virus (HBV) loads but rarely result in a functional cure (defined as sustained HBsAg loss). We report the discovery of a novel, 4-pyridone compound, SAG-524, a potent and orally bioavailable small molecule inhibitor of HBV ...
Takehisa Watanabe   +6 more
openaire   +2 more sources

STUDY OF HBEAG, HBV DNA IN PATIENTS WITH HBV- RELATED CIRRHOSIS

Journal of Medicine and Pharmacy, 2012
Background: The recent studies concerning antiviral therapy in HBV-related cirrhosis showed the promising results. This study aimed to assess /The aim of this study was to assess the quantity of HBeAg, HBV DNA and identify some related factors in patients with HBV-induced cirrhosis.
Van Huy Tran   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy